Symbols

Symbols

RARE

RARE

Ultragenyx's chart triggers Bollinger Bands Narrowing, KDJ Death Cross, and Bearish Marubozu.

Ultragenyx Pharmaceutical's Valuation Gap Widen Amidst Aggressive Growth Forecasts.

Wednesday Nov 05, 2025

Ultragenyx: TD Cowen Keeps Buy Rating, Lowers PT to $75 from $86

Ultragenyx's 15min chart shows Bollinger Bands Narrowing and KDJ Death Cross.

Ultragenyx: Truist Securities maintains Buy, PT down to $90 from $100.

Ultragenyx Pharmaceutical Reports Q3 Net Loss Widening, Revenue Growth

Ultragenyx Anticipates 14%-20% Revenue Growth in 2025, Secures $400M OMERS Financing for Late-Stage Pipeline

Tuesday Nov 04, 2025

Ultragenyx Sells 25% of Crysvita Royalties to OMERS Life Sciences for $400 Million

Ultragenyx Reaffirms 2025 Revenue Guidance for Rare Disease Therapeutics

Ultragenyx Q3 revenue $160mln, Crysvita $112mln, Dojolvi $24mln.

Ultragenyx's 15min chart shows Bollinger Bands Narrowing and KDJ Death Cross.

Ultragenyx's 15min chart shows MACD Death Cross, Bollinger Bands expanding downward.

Thursday Oct 30, 2025

Ultragenyx Initiates Aurora Study for GTX-102 in Angelman Syndrome Patients

Ultragenyx Doses First Patient in Aurora Study for Angelman Syndrome Treatment

Ultragenyx Doses First Patient in Aurora Study for Angelman Syndrome Treatment

Tuesday Oct 28, 2025

Ultragenyx Pharmaceutical's Valuation: Is $35.31 a Steal After 21% Surge?

Ultragenyx to Report Q3 2025 Earnings and Provide Corporate Update

Ultragenyx: MACD Death Cross, KDJ Death Cross trigger on 15-minute chart.

Monday Oct 27, 2025

Ultragenyx: MACD Death Cross, KDJ Death Cross trigger on 15-minute chart.

Ultragenyx's 15min chart sees KDJ Golden Cross, Bullish Marubozu signal.